PLPL (Plandai Biotechnology) Debt-to-Asset : 0.00 (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Plandai Biotechnology Debt-to-Asset?

Plandai Biotechnology PLPL -90.00% Debt-to-Asset is 0.00 as of Jun. 2023.

Plandai Biotechnology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.05 Mil. Plandai Biotechnology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.00 Mil. Plandai Biotechnology's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was $0.00 Mil.

Plandai Biotechnology  (OTCPK:PLPL) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Plandai Biotechnology Debt-to-Asset Related Terms

Plandai Biotechnology Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Plandai Biotechnology's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology Debt-to-Asset Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 1.71 2.22 0.00 0.00

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.71 2.22 0.00 0.00

PLPL vs CRGH, TCRI, MAYX: Debt-to-Asset Comparison

For the Specialty Business Services subindustry, Plandai Biotechnology's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plandai Biotechnology Debt-to-Asset vs Business Services Industry

For the Business Services industry and Industrials sector, Plandai Biotechnology's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's Debt-to-Asset falls into.


Plandai Biotechnology Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Plandai Biotechnology's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.05 + 0) / 0
=N/A

Plandai Biotechnology's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.05 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
Plandai Biotechnology (PLPL) has a Debt-to-Asset of 0.00 as of Jun. 2023. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Plandai Biotechnology and its competitors.
Is Plandai Biotechnology's Debt-to-Asset too high?
Plandai Biotechnology's current Debt-to-Asset is 0.00.
How does Plandai Biotechnology's Debt-to-Asset compare to CRGH and TCRI?
Plandai Biotechnology's Debt-to-Asset of 0.00 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Business Services company?
A good Debt-to-Asset depends on the Business Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Plandai Biotechnology and its competitors. Plandai Biotechnology's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plandai Biotechnology stock overvalued right now?
Plandai Biotechnology (PLPL) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Plandai Biotechnology (PLPL), the current Debt-to-Asset is 0.00 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plandai Biotechnology Business Description

Address Xinyi Road, Sector 5, No. 7, 57th Floor - 1, Xinyi District, Taipei, TWN, 330
Plandai Biotechnology Inc is engaged in catering and catering management operations in Taiwan.